Long term outcome and sequelae in patients after acute thrombotic thrombocytopenic purpura episodes

被引:16
作者
Falter, T. [1 ,2 ]
Alber, K. J. [1 ]
Scharrer, I. [1 ]
机构
[1] Univ Med Ctr Mainz, Dept Med Haematol Oncol & Pneumol 3, Mainz, Germany
[2] Univ Med Ctr Mainz, Ctr Thrombosis & Haemostasis, Mainz, Germany
来源
HAMOSTASEOLOGIE | 2013年 / 33卷 / 02期
关键词
Thrombotic thrombocytopenic purpura; ADAMTS13; activity; long term outcome; neurocognitive impairment; VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC-SYNDROME; FACTOR-CLEAVING PROTEASE; UPSHAW-SCHULMAN SYNDROME; PLASMA-EXCHANGE; TTP-HUS; ADAMTS13; METALLOPROTEASE; RITUXIMAB; SPLENECTOMY;
D O I
10.5482/HAMO-12-11-0019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on 21 patients with idiopathic thrombotic thrombocytopenic purpura (TTP) whose courses of disease have been followed from the respective diagnosis until now. They had a documented ADAMTS13 activity below 5%, a high autoantibody titer and detectable ultralarge von Willebrand factor (VWF) multimers during their episodes. The initial diagnosis was based on clinical symptoms and on laboratory parameters: thrombocytopenia, haemolytic anaemia, schistocytes and an increased LDH level. 103 acute clinical episodes of 21 TTP-patients during a time period of 30 years are described. Case histories, comorbidities and sequelae were retrospectively documented. Results, conclusion:Although patients are con.: sistently in a prothrombotic status, clinical acute manifestations only occur after triggering. Most common trigger factors are gastrointestinal infections and pregnancy. The relapse risk per month is 0.026; men have a higher risk for relapses (0.044) than women (0.021). Patients recover physically well, except for renal insufficiency in four cases. Nevertheless, major portion of patients suffers persistently from depression, anxiety disorders and persistent neurocognitive impairments.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 40 条
[1]   Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias [J].
Allford, SL ;
Hunt, BJ ;
Rose, P ;
Machin, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) :556-573
[2]   Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study [J].
Altuntas, Fevzi ;
Aydogdu, Ismet ;
Kabukcu, Sibel ;
Kocyigit, Ismail ;
Cikim, Kerim ;
Sari, Ismail ;
Erkut, M. Ali ;
Eser, Bulent ;
Ozturk, Ahmet ;
Kaya, Emin ;
Cetin, Mustafa ;
Keskin, Ali ;
Unal, Ali .
TRANSFUSION AND APHERESIS SCIENCE, 2007, 36 (01) :57-67
[3]   THROMBOTIC THROMBOCYTOPENIC PURPURA - REPORT OF 16 CASES AND REVIEW OF LITERATURE [J].
AMOROSI, EL ;
ULTMANN, JE .
MEDICINE, 1966, 45 (02) :139-+
[4]   Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura [J].
Aqui, NA ;
Stein, SH ;
Konkle, BA ;
Abrams, CS ;
Strobl, FJ .
JOURNAL OF CLINICAL APHERESIS, 2003, 18 (02) :51-54
[5]   Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura [J].
Banno, F ;
Kokame, K ;
Okuda, T ;
Honda, S ;
Miyata, S ;
Kato, H ;
Tomiyama, Y ;
Miyata, T .
BLOOD, 2006, 107 (08) :3161-3166
[6]   IMPROVED SURVIVAL IN THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC UREMIC SYNDROME - CLINICAL-EXPERIENCE IN 108 PATIENTS [J].
BELL, WR ;
BRAINE, HG ;
NESS, PM ;
KICKLER, TS .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) :398-403
[7]   Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13) [J].
Böhm, M ;
Vigh, T ;
Scharrer, I .
ANNALS OF HEMATOLOGY, 2002, 81 (08) :430-435
[8]   ADAMTS13: a new link between thrombosis and inflammation [J].
Chauhan, Anil K. ;
Kisucka, Janka ;
Brill, Alexander ;
Walsh, Meghan T. ;
Scheiflinger, Friedrich ;
Wagner, Denisa D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (09) :2065-2074
[9]   Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab [J].
Chemnitz, Jens Marcus ;
Uener, Jens ;
Hallek, Michael ;
Scheid, Christof .
ANNALS OF HEMATOLOGY, 2010, 89 (10) :1029-1033
[10]   Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure [J].
Claus, Ralf A. ;
Bockmeyer, Clemens L. ;
Budde, Ulrich ;
Kentouche, Karim ;
Sossdorf, Maik ;
Hilberg, Thomas ;
Schneppenheim, Reinhart ;
Reinhart, Konrad ;
Bauer, Michael ;
Brunkhorst, Frank M. ;
Loesche, Wolfgang .
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (02) :239-247